Moreno C, Aiello A, Di Virgilio R, Mazzotta V, Antinori A. Cost-effectiveness analysis of nirmatrelvir/ritonavir in adult patients at high risk of progressing to severe COVID-19. Grhta [Internet]. 2025 Jul. 17 [cited 2025 Jul. 22];11(1):168-76. Available from: https://journals.aboutscience.eu/index.php/grhta/article/view/3403